Search
Harbinger Health’s Steve Hahn on the science of early cancer Dx after raising a $140M Series B
Steve Hahn describes how Harbinger Health is trying to catch the earliest signals of cancer, and how this information might be used.
Sep 28, 2023
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.
bottom of page